AcandiS Stenting of Intracranial STENosis - regisTry

NCT ID: NCT03902444

Last Updated: 2023-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-31

Study Completion Date

2025-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ASSISTENT is designed to collect comprehensive information on technical and clinical safety of the use of Credo® stent together with the NeuroSpeed® PTA balloon catheter in clinical practice in an open registry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ASSISTENT is subdivided into two components. The first part only requires recording of data acquired in routine clinical practice during the treatment of patients with intracranial stenosis with the self-expandable Credo® stent until discharge. This comprises demographic data, data concerning the qualifying clinical event, limited data on medical history and medication, information about the intervention including technical success and periprocedural complications or events, and information about events and clinical status during the in-hospital treatment until hospital discharge.

The second part of the registry consists of a follow-up visit 30 days after the interventional procedure which will be conducted outside of clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Credo® Stent and NeuroSpeed® PTA balloon catheter

Patients treated with Credo® Stent and NeuroSpeed® PTA balloon catheter in the clinical routine

Credo® Stent, NeuroSpeed® PTA balloon catheter

Intervention Type DEVICE

a self-expanding stent is used together with a PTA balloon catheter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Credo® Stent, NeuroSpeed® PTA balloon catheter

a self-expanding stent is used together with a PTA balloon catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Treatment with Credo® for symptomatic atherosclerotic intracranial artery stenosis (see product IFU)
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Acandis GmbH

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Götz Thomalla, MD

Role: PRINCIPAL_INVESTIGATOR

Unversity Medical Center Hamburg-Eppendorf

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Knappschaftskrankenhaus Bochum

Bochum, , Germany

Site Status RECRUITING

Uniklinik Köln

Cologne, , Germany

Site Status RECRUITING

Universitätsklinikum Düsseldorf Institut für Diagnostische und Interventionelle Radiologie Abteilung Neuroradiologie

Düsseldorf, , Germany

Site Status RECRUITING

Alfried Krupp Krankenhaus Essen, Klinik für Neuroradiologie

Essen, , Germany

Site Status RECRUITING

Institut für Diagnostische und Interventionelle Neuroradiologie Universitätsmedizin Göttingen

Göttingen, , Germany

Site Status RECRUITING

Universitätsklinikum Hamburg-Eppendorf

Hamburg, , Germany

Site Status RECRUITING

Asklepios Klinik Altona, Fachbereich Neuroradiologie

Hamburg, , Germany

Site Status RECRUITING

Universitätsklinikum Heidelberg Abteilung für Neuroradiologie

Heidelberg, , Germany

Site Status RECRUITING

Universitätsklinikum Homburg

Homburg, , Germany

Site Status RECRUITING

Klinikum Ingolstadt

Ingolstadt, , Germany

Site Status RECRUITING

Otto-von-Guericke-Universität Magdeburg Universitätsklinik für Neuroradiologie

Magdeburg, , Germany

Site Status RECRUITING

Kliniken Maria Hilf GmbH Mönchengladbach, Klinik für Diagnostische und Interventionelle Radiologie und Neuroradiologie

Mönchengladbach, , Germany

Site Status RECRUITING

Evangelisches Krankenhaus Oldenburg; Medizinischer Campus Universität Oldenburg

Oldenburg, , Germany

Site Status RECRUITING

Klinikum Osnabrück, Klinik für Neurologie

Osnabrück, , Germany

Site Status RECRUITING

KLINIKUM VEST GMBH Knappschaftskrankenhaus Klinik für Radiologie und Neuroradiologie

Recklinghausen, , Germany

Site Status RECRUITING

St. Lukas Klinik GmbH, radprax MVZ GmbH Solingen

Solingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Acandis GmbH

Role: CONTACT

+49 723 1155 00

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christoph Kabbasch, MD

Role: primary

Bernd Turowski, Prof.

Role: primary

Rene Chapot, Prof.

Role: primary

Christian Riedel, Prof.

Role: primary

Götz Thomalla, MD

Role: primary

Bernd Eckert, Prof

Role: primary

Markus Möhlenbruch, MD

Role: primary

Wolfgang Reith, Prof.

Role: primary

Daniel Behme, PD Dr.

Role: primary

Prof. Ringelstein

Role: primary

Christian Mathys, MD

Role: primary

Lars Krause, MD

Role: primary

Christian Loehr, Dr.

Role: primary

Hannes Nordmeyer, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASSISTENT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VISSIT Intracranial Stent Study for Ischemic Therapy
NCT00816166 TERMINATED PHASE2/PHASE3
Neuroform Atlas Stent System Study
NCT02340585 COMPLETED NA
VerifyNow French Registry
NCT00753753 COMPLETED